Prenetics Global Limited (PRE) Stock Analysis & Winston Score

Prenetics Global Limited is a health sciences company based in Hong Kong that focuses on genetic testing, cancer screening, and consumer health products. Its main brands include CircleDNA, which sells at-home DNA test kits that tell people about their health risks and ancestry, and Insighta, which works on blood-based cancer detection tests. The company serves everyday consumers as well as healthcare providers across Asia and parts of Europe. Prenetics makes money primarily by selling DNA test kits directly to consumers and through partnerships with healthcare systems and insurers. It operates mainly in Hong Kong, the United Kingdom, and Southeast Asia, and generates a relatively high gross margin for a diagnostics company, though it is currently spending significantly more than it earns, resulting in operating losses. The key growth driver is its early cancer detection business, which could expand if its screening tests gain clinical validation and regulatory approval — but continued cash burn remains a serious risk for the company.